IMMX Immix Biopharma, Inc.
Nasdaq · SEC CIK 1873835 · EDGAR
- Bought, last 12 months
- $10.0K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 84 since 2021-12-20, latest 2026-05-29 17:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Morris Gabriel S | CFO, Dir | $5,067 | — |
| Rachman Ilya M | CEO, COB, Dir | $4,976 | — |
| Chudnovsky Yekaterina | Dir | — | — |
| Hsu Jason | Dir | — | — |
| Ng Carey | Dir | — | — |
| Marquet Magda | Dir | — | — |
| Adams Helen C. | Dir | — | — |
| BUCHAN JANE | Dir | — | — |
| CHANG NANCY T | Dir | — | — |
Transactions 52
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | Adams Helen C. | Dir | A - Grant | $0.00 | +6,250 | 181.0K | +4% | $0 |
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | Ng Carey | Dir | A - Grant | $0.00 | +6,250 | 26.2K | +31% | $0 |
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | Marquet Magda | Dir | A - Grant | $0.00 | +6,250 | 52.3K | +14% | $0 |
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | CHANG NANCY T | Dir | A - Grant | $0.00 | +6,250 | 428.2K | +1% | $0 |
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | Chudnovsky Yekaterina | Dir | A - Grant | $0.00 | +6,250 | 6,250 | New | $0 |
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | Hsu Jason | Dir | A - Grant | $0.00 | +6,250 | 899.2K | +0.7% | $0 |
| D | 2026-05-29 17:05 | 2026-05-22 | IMMX | BUCHAN JANE | Dir | A - Grant | $0.00 | +6,250 | 28.7K | +28% | $0 |
| D | 2025-12-10 | 2025-12-10 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $6.58 | +770 | 291.4K | +0.3% | +$5,067 |
| DI | 2025-12-10 | 2025-12-08 | IMMX | Morris Gabriel S | CFO, Dir | X - OptEx | $0.8 | +156.0K | 426.8K | +58% | +$124.8K |
| 2025-12-10 | 2025-12-10 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $6.67 | +746 | 1.14M | +0.1% | +$4,976 | |
| 2025-09-17 | 2025-09-16 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $1.97 | +2,600 | 290.7K | +0.9% | +$5,122 | |
| 2025-09-17 | 2025-09-17 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $2.02 | +2,500 | 1.14M | +0.2% | +$5,050 | |
| 2025-06-20 | 2025-06-18 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $2.28 | +2,225 | 288.1K | +0.8% | +$5,073 | |
| 2025-06-20 | 2025-06-18 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $2.30 | +2,178 | 1.14M | +0.2% | +$5,009 | |
| M | 2024-12-26 | 2024-12-20+ | IMMX | Hsu Jason | Dir | P - Purchase | $2.19 | +47.7K | 853.0K | +6% | +$104.3K |
| M | 2024-08-26 | 2024-08-21+ | IMMX | Hsu Jason | Dir | P - Purchase | $2.24 | +23.1K | 845.3K | +3% | +$51.7K |
| 2024-08-19 | 2024-08-16 | IMMX | Ng Carey | Dir | P - Purchase | $1.86 | +10.0K | 20.0K | +100% | +$18.6K | |
| M | 2024-07-31 | 2024-07-18+ | IMMX | Hsu Jason | Dir | P - Purchase | $2.12 | +9,200 | 816.2K | +1% | +$19.5K |
| 2024-06-10 | 2024-06-07 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $2.12 | +2,500 | 285.8K | +0.9% | +$5,300 | |
| 2024-06-10 | 2024-06-07 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $2.13 | +2,600 | 1.14M | +0.2% | +$5,538 | |
| 2024-06-05 | 2024-06-04 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $1.81 | +3,300 | 1.13M | +0.3% | +$5,973 | |
| 2024-06-05 | 2024-06-04 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $1.81 | +3,300 | 283.3K | +1% | +$5,973 | |
| DM | 2024-05-20 | 2024-05-15+ | IMMX | BUCHAN JANE | Dir | A - Grant | $0.00 | +2,459 | 21.3K | +13% | $0 |
| M | 2024-05-20 | 2024-05-15+ | IMMX | Adams Helen C. | Dir | A - Grant | $0.00 | +162.0K | 100.7K | New | $0 |
| 2024-05-20 | 2024-05-20 | IMMX | Rachman Ilya M | CEO, COB, Dir | A - Grant | — | +218.4K | 1.13M | +24% | — | |
| M | 2024-05-20 | 2024-05-15+ | IMMX | Marquet Magda | Dir | A - Grant | $0.00 | +46.2K | 25.0K | New | $0 |
| MI | 2024-05-20 | 2024-05-20 | IMMX | Morris Gabriel S | CFO, Dir | A - Grant | — | +48.3K | 270.8K | +22% | — |
| 2024-05-20 | 2024-05-20 | IMMX | Morris Gabriel S | CFO, Dir | A - Grant | — | +194.2K | 280.0K | +226% | — | |
| 2024-05-14 | 2024-05-14 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $2.25 | +4,300 | 912.0K | +0.5% | +$9,675 | |
| 2024-05-14 | 2024-05-14 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $2.23 | +4,500 | 85.8K | +6% | +$10.0K | |
| M | 2023-12-12 | 2023-12-08+ | IMMX | Hsu Jason | Dir | P - Purchase | $4.76 | +56.0K | 782.0K | +8% | +$266.8K |
| M | 2023-09-18 | 2023-09-11+ | IMMX | Hsu Jason | Dir | P - Purchase | $2.78 | +72.0K | 750.0K | +11% | +$200.4K |
| 2023-09-15 | 2023-09-14 | IMMX | Ng Carey | Dir | P - Purchase | $2.58 | +10.0K | 10.0K | New | +$25.8K | |
| 2023-09-14 | 2023-09-12 | IMMX | Adams Helen C. | Dir | P - Purchase | $2.96 | +13.0K | 13.0K | New | +$38.5K | |
| 2023-09-12 | 2023-09-08 | IMMX | Hsu Jason | Dir | P - Purchase | $2.53 | +10.0K | 685.0K | +1% | +$25.3K | |
| 2023-09-11 | 2023-09-07 | IMMX | BUCHAN MELISSA JANE | Dir | P - Purchase | $2.46 | +20.0K | 20.0K | New | +$49.2K | |
| I | 2023-09-08 | 2023-09-06 | IMMX | Marquet Magda | Dir | P - Purchase | $2.47 | +9,000 | 20.0K | +82% | +$22.2K |
| I | 2023-09-06 | 2023-09-05 | IMMX | Marquet Magda | Dir | P - Purchase | $2.47 | +10.0K | 11.0K | +1,000% | +$24.7K |
| I | 2023-09-05 | 2023-08-31 | IMMX | Marquet Magda | Dir | P - Purchase | $2.01 | +1,000 | 1,000 | New | +$2,010 |
| 2022-11-15 | 2022-11-14 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $0.94 | +5,200 | 81.3K | +7% | +$4,888 | |
| M | 2022-11-15 | 2022-11-14 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $1.01 | +5,200 | 907.5K | +0.6% | +$5,230 |
| A | 2022-07-22 | 2022-07-14 | IMMX | Senn Sean | Under 10% owner | S - Sale | $2.75 | -200 | 899.8K | -0.0% | -$550 |
| 2022-07-18 | 2022-07-14 | IMMX | Senn Sean | 10% | S - Sale | $2.75 | -200 | 899.8K | -0.0% | -$550 | |
| 2021-12-20 | 2021-12-20 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $5.00 | +2,500 | 902.5K | +0.3% | +$12.5K | |
| D | 2021-12-20 | 2021-12-20 | IMMX | Morris Gabriel S | CFO, Dir | C - Cnv Deriv | $0.85 | +74.1K | 74.1K | New | +$63.0K |
| DMI | 2021-12-20 | 2021-12-20 | IMMX | Morris Gabriel S | CFO, Dir | C - Cnv Deriv | $0.85 | +246.7K | 246.7K | New | +$209.7K |
| D | 2021-12-20 | 2021-12-20 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $5.00 | +2,000 | 76.1K | +3% | +$10.0K |
| DI | 2021-12-20 | 2021-12-20 | IMMX | Hsu Jason | Dir | C - Cnv Deriv | $0.85 | +3.92M | 3.92M | New | +$3.33M |
| DI | 2021-12-20 | 2021-12-20 | IMMX | Hsu Jason | Dir | P - Purchase | $5.00 | +50.0K | 50.0K | New | +$250.0K |
| DI | 2021-12-20 | 2021-12-20 | IMMX | Ng Carey | Dir | P - Purchase | $5.00 | +25.0K | 1.03M | +2% | +$125.0K |
| DI | 2021-12-20 | 2021-12-20 | IMMX | Ng Carey | Dir | C - Cnv Deriv | $0.85 | +1.00M | 1.00M | New | +$850.2K |
| M | 2021-12-20 | 2021-12-17+ | IMMX | Torchilin Vladimir P | Scientific Co-Founder | P - Purchase | $4.78 | +5,200 | 902.2K | +0.6% | +$24.8K |
Purchase Sale Sale after option exercise All abbreviations